MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
24.16
+0.18
+0.75%
After Hours: 24.75 +0.59 +2.44% 19:36 12/12 EST
OPEN
24.10
PREV CLOSE
23.98
HIGH
24.63
LOW
23.71
VOLUME
367.44K
TURNOVER
--
52 WEEK HIGH
29.80
52 WEEK LOW
11.51
MARKET CAP
1.57B
P/E (TTM)
-7.0460
1D
5D
1M
3M
1Y
5Y
1D
Pharvaris (NasdaqGS:PHVS): Reassessing Valuation After RAPIDe-3 Phase 3 Success and Deucrictibant Commercial Progress
Simply Wall St · 9h ago
Weekly Report: what happened at PHVS last week (1201-1205)?
Weekly Report · 6d ago
Pharvaris (PHVS): Reassessing Valuation After Strong RAPIDe-3 Phase 3 Success in Hereditary Angioedema
Simply Wall St · 12/06 18:14
Pharvaris Is Maintained at Outperform by Oppenheimer
Dow Jones · 12/04 18:20
Oppenheimer Maintains Outperform on Pharvaris, Raises Price Target to $50
Benzinga · 12/04 18:09
Pharvaris Stock Gains on HAE Drug Meeting Late-Stage Study Goals
NASDAQ · 12/04 18:09
Pharvaris Is Maintained at Buy by Guggenheim
Dow Jones · 12/04 14:04
Guggenheim Maintains Buy on Pharvaris, Raises Price Target to $39
Benzinga · 12/04 13:54
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.